2023
DOI: 10.1016/j.ijpharm.2023.122962
|View full text |Cite
|
Sign up to set email alerts
|

Bio-adhesive and ROS-scavenging hydrogel microspheres for targeted ulcerative colitis therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 61 publications
0
4
0
Order By: Relevance
“…Wild-type mice supplemented with selenium under the same conditions survived normally. A number of studies have been conducted to show that overexpression of reactive oxygen species (ROS) leads to inflammatory bowel disease due to damage to the intestinal mucosal barrier ( Sun et al, 2023 ; Yao et al, 2023 ). The study by Huang et al showed that scavenging ROS toxicity, improving cellular antioxidant capacity and alleviating cellular ERS by increasing GPX1 expression could greatly rescue the cell death situation ( Tao et al, 2023 ).…”
Section: Discussionmentioning
confidence: 99%
“…Wild-type mice supplemented with selenium under the same conditions survived normally. A number of studies have been conducted to show that overexpression of reactive oxygen species (ROS) leads to inflammatory bowel disease due to damage to the intestinal mucosal barrier ( Sun et al, 2023 ; Yao et al, 2023 ). The study by Huang et al showed that scavenging ROS toxicity, improving cellular antioxidant capacity and alleviating cellular ERS by increasing GPX1 expression could greatly rescue the cell death situation ( Tao et al, 2023 ).…”
Section: Discussionmentioning
confidence: 99%
“…MPO is mainly secreted by activated neutrophils and is a viable clinical biomarker for evaluating disease severity. 40,41 The significant increase in MPO activity indicated active colitis of the mice in the DSS group (Fig. S9C †).…”
Section: Biomaterials Science Papermentioning
confidence: 97%
“…52 The concentration of reactive oxygen species (ROS) in the area of inflammation was found to be 10–100 times higher, providing a target and anchor for nanoparticles. 53–56 ROS-responsive moieties have been taken advantage of in the preparation of ROS-responsive prodrugs, such as the typical arylboronates, thiazolidinone, and selenium- or sulfur-containing classes. 57 Such nanocarriers can degrade selectively at the inflamed site with higher levels of ROS and release TNF-α siRNA with a strong siRNA gene silencing activity.…”
Section: Therapeutic Targeting Strategymentioning
confidence: 99%